Your browser doesn't support javascript.
loading
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
Kared, Hassen; Wolf, Asia-Sophia; Alirezaylavasani, Amin; Ravussin, Anthony; Solum, Guri; Tran, Trung The; Lund-Johansen, Fridtjof; Vaage, John Torgils; Nissen-Meyer, Lise Sofie; Nygaard, Unni C; Hungnes, Olav; Robertson, Anna H; Næss, Lisbeth Meyer; Trogstad, Lill; Magnus, Per; Munthe, Ludvig A; Mjaaland, Siri.
Afiliação
  • Kared H; KG Jebsen Centre for B cell malignancy, Institute of Clinical medicine, University of Oslo, Oslo, Norway. hassen.kared@medisin.uio.no.
  • Wolf AS; Department of Immunology, Oslo University Hospital, Oslo, Norway. hassen.kared@medisin.uio.no.
  • Alirezaylavasani A; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Ravussin A; KG Jebsen Centre for B cell malignancy, Institute of Clinical medicine, University of Oslo, Oslo, Norway.
  • Solum G; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Tran TT; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Vaage JT; ImmunoLingo Convergence Center, Institute of Clinical medicine, University of Oslo, Oslo, Norway.
  • Nissen-Meyer LS; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Nygaard UC; ImmunoLingo Convergence Center, Institute of Clinical medicine, University of Oslo, Oslo, Norway.
  • Hungnes O; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Robertson AH; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Næss LM; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Trogstad L; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Magnus P; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Munthe LA; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Mjaaland S; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Nat Commun ; 13(1): 4165, 2022 07 18.
Article em En | MEDLINE | ID: mdl-35851055
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article